CYMABAY THERAPEUTICS, INC.
7575 Gateway Blvd., Suite 110
Newark, CA 94560
(510) 293-8800
July 9, 2020
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn: Ada Sarmento
| RE: | CymaBay Therapeutics, Inc. |
Registration Statement on Form S-3
File No. 333-239670
Ladies and Gentlemen:
CymaBay Therapeutics, Inc. hereby requests that the Securities and Exchange Commission take appropriate action to cause the above-referenced Registration Statement on Form S-3 to become effective on July 13, 2020, at 4:00 p.m., Eastern Time, or as soon thereafter as is practicable.
| Very truly yours, | ||
| CymaBay Therapeutics, Inc. | ||
| By: | /s/ Sujal Shah | |
| Sujal Shah | ||
| President and Chief Executive Officer | ||
